Canada’s major pharma lobby is objecting to the removal of a requirement in the new North American trade deal that would have extended the data protection period for biological drugs in Canada from eight years to 10.  The amendments to the trade pact, dubbed the new NAFTA, were published on Wednesday, and came after Democrats […]

Source: Pharma lobby criticizes removal of data protection rules in new NAFTA – iPolitics